Nnormal, the innovative trail running brand co-founded by Kilian Jornet, has announced the launch of the Cadi—a bold new entry into their lineup that represents a significant departure from the brand's traditional philosophy of minimalism and speed. The Cadi arrives in March 2026 as Nnormal's most cushioned model to date, featuring a substantial 35mm heel and 29mm forefoot stack height paired with the brand's all-new X Pure supercritical EVA foam. This is a deliberate strategic move that signals Nnormal's ambition to serve ultra-runners and technical terrain specialists who prioritize comfort and protection on long mountain efforts over the stripped-down, fast-and-light ethos that defined earlier generations of Nnormal shoes.
The genesis of the Cadi reflects the brand's evolution and recognition that serious ultra-runners need options tailored to different race distances and terrain demands. While Nnormal has built a loyal following among speed-focused fell runners and skyrunners, the ultra-running community increasingly demands a shoe that can deliver marathon-plus durability and day-long comfort without sacrificing the traction and responsiveness that technical terrain requires. The Cadi answers that call with confidence, targeting the sweet spot between the lightweight, race-focused models in Nnormal's catalog and the more cushioned competitors from Hoka, La Sportiva, and other established trail brands. For runners tackling ultra-marathons in mountainous terrain—be it the Alps, Rockies, or other vertically challenging landscapes—the Cadi promises to be a game-changing option.
The X Pure supercritical EVA foam is the star of the Cadi's technical story. This proprietary cushioning material was developed specifically for this shoe with an emphasis on maintaining energy return and responsiveness despite the generous stack heights. Supercritical EVA represents an advanced manufacturing process that creates a more consistent, resilient foam than traditional EVA, reducing the performance degradation that typically occurs in thicker cushioning during long efforts. The heel-to-toe drop remains moderate, typical of Nnormal's preference for a more natural foot strike and anatomically considerate platform. The outsole, meanwhile, employs Vibram's latest traction technology, proven on demanding technical and rocky terrain, ensuring the Cadi performs capably on steep descents and loose, exposed sections where grip becomes critical.
Kilian Jornet's involvement in the brand remains central to Nnormal's identity and direction. As one of the greatest ultra-runners and skyrunners in history, Jornet's input shapes every shoe that bears the Nnormal name, and the Cadi is no exception. This isn't a shoe designed by committee or outsourced to third-party development studios; it's a product shaped by someone who has spent decades testing equipment in the most demanding environments on the planet. That pedigree matters to runners considering an investment in the Cadi, as it suggests the shoe has been vetted against the toughest standards imaginable. Whether you're tackling a classic mountain ultra like the UTMB, a continuous 50K push through technical terrain, or establishing a personal FKT on a remote mountain range, the Cadi is engineered to keep pace with your ambitions.
The Cadi's arrival also signals Nnormal's confidence in the global ultra-running market and their ability to compete with established giants. Pricing is expected to be competitive with similarly positioned shoes from other premium trail brands, likely landing in the $180–$220 range depending on market and retail channel. For runners seeking Nnormal's distinctive design philosophy and mountain heritage but need more cushioning for longer efforts, the Cadi represents an exciting option. The shoe will be available through Nnormal's official website and select specialty running retailers starting in March 2026. If you're considering making the move to Nnormal or simply looking for a premium ultra-focused trail shoe that can handle both speed and sustainability, the Cadi deserves serious consideration.